Szpital Jana Pawla II Oddzial Neuoinfekcji Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2001
NCT00161824
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

Szpital Jana Pawla II Oddzial Neuroinfekcji, Krakow, Poland